Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-16-Speech-2-255"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-12-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medicinal products2
lpv:document identification number	"en.20031216.6.2-255"2
lpv:hasSubsequent	lp_eu:2003-12-16-Speech-2-2562
lpv:speaker	lp:Giorgos Dimitrakopoulos2
lpv:spokenAs	substitute; Committee on Legal Affairs and the Internal Market (2002-01-17--2004-07-19)3 member; AFCO (2002-01-17--2004-07-19)3 member_of_the_bureau; EPP-ED (2002-03-08--2004-07-19)3 vice-president; European Parliament (2002-01-15--2004-07-19)3 substitute; Delegation to the EU-Lithuania Joint Parliamentary Committee (2002-02-07--2004-04-30)3 unknown; Nea Dimokratia (1999-07-20--2004-07-19)3 vice-president; Parliament's Bureau (2002-01-15--2004-07-19)3
lpv:translated text	"The next item is the joint debate on three recommendations for second reading, on behalf of the Committee on the Environment, Public Health and Consumer Policy. on the laying down of Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (10949/2/2003 – C5-0463/2003 – 2001/0252(COD)) (Rapporteur: Mrs Müller) A5-0446/2006 , on the Community Code relating to medicinal products for human use (10950/3/2003 – C5-0464/2003 – 2001/0253(COD)) (Rapporteur: Mrs Grossetête) on the Community Code relating to veterinary medicinal products (10950/3/2003 – C5-0464/2003 – 2001/0253(COD)) (Rapporteur: Mrs Grossetête)"@en1
lpv:unclassifiedMetadata	"President."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph